Top

European Journal of Nutrition

Published in:

01-04-2020 | Hashimoto Thyroiditis | Review

Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto’s thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies

Authors: Mario Štefanić, Stana Tokić

Published in: European Journal of Nutrition | Issue 3/2020

Abstract

Purpose

Available evidence on the relation between vitamin D status and Hashimoto’s thyroiditis (HT) remains inconsistent. We conducted a meta-analysis of serum 25-hydoxyvitamin [25(OH)D] concentrations in HT, and examined how the strength of this relationship varies as a function of several moderating factors.

Methods

Twenty-six observational, case–control studies, published before Feb 20, 2018, were located using Google Scholar, PubMed, Web of Science, SCOPUS, LILACS and SCIELO. Study quality was assessed and random-effects models were used, along with univariate mixed-effect meta-regression, for all analyses.

Results

The 25 studies (2695 cases, 2263 controls) confirmed lower serum 25(OH)D concentrations in HT compared to healthy controls, with Cohen’s d − 0.62 (95% CI − 0.89, − 0.34; P = 1.5 × 10⁻⁵) and substantial heterogeneity between studies. HT showed an odds ratio (OR) of 3.21 (1.94–5.3; P = 5.7 × 10⁻⁶) for 25(OH)D deficiency (cut-off 20 ng/mL) against healthy controls. A corrected Cohen’s d of − 0.43 [(− 0.76, − 0.09), P = 0.013] was obtained by trim-and-fill adjustment for publication bias. The association was consistent across Asian and European studies, pediatric and adult population, high- and moderate-quality studies. Near-equatorial latitudes (< 35° N/S, P = 3.4 × 10⁻⁴) and moderate-income economy (gross national income (GNI) 1000 < US$ < 12,000, P = 0.012) were associated with more discrepant 25(OH)D concentrations between the groups. Higher latitude (P = 0.0047), and higher mean body mass index (P = 0.006, 10 studies) were associated with smaller Cohen’s d by univariate meta-regression, with evidence of nonlinear moderation by GNI (P = 3.5 × 10⁻⁶), and mean serum thyrotropin in affected individuals (P = 0.017, 21 studies).

Conclusion

The present work shows a significant association between circulating 25(OH)D and HT, partly resolves mixed findings by identifying the empirical moderators contributing to overall heterogeneity, and highlights HT patient groups and the conditions under which the association is strongest.

Available only for authorised users

Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348(26):2646–2655CrossRef

Booth DR, Ding N, Parnell GP, Shahijanian F, Coulter S, Schibeci SD, Atkins AR, Stewart GJ, Evans RM, Downes M, Liddle C (2016) Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases. Genes Immun 17(4):213–219. https://doi.org/10.1038/gene.2016.12 CrossRefPubMedPubMedCentral

Zeitelhofer M, Adzemovic MZ, Gomez-Cabrero D, Bergman P, Hochmeister S, N’diaye M, Paulson A, Ruhrmann S, Almgren M, Tegnér JN, Ekström TJ, Guerreiro-Cacais AO, Jagodic M (2017) Functional genomics analysis of vitamin D effects on CD4 + T cells in vivo in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 114(9):E1678–E1687. https://doi.org/10.1073/pnas.1615783114 CrossRefPubMed

Dankers W, Colin EM, van Hamburg JP, Lubberts E (2017) Vitamin D in Autoimmunity: molecular Mechanisms and Therapeutic Potential. Front Immunol 7:697. https://doi.org/10.3389/fimmu.2016.00697 CrossRefPubMedPubMedCentral

Kim D (2017) The role of vitamin D in thyroid diseases. Int J Mol Sci 18(9):E1949. https://doi.org/10.3390/ijms18091949 CrossRefPubMed

Nettore IC, Albano L, Ungaro P, Colao A, Macchia PE (2017) Sunshine vitamin and thyroid. Rev Endocr Metab Disord 18(3):347–354. https://doi.org/10.1007/s11154-017-9406-3 CrossRefPubMedPubMedCentral

Hu S, Rayman MP (2017) Multiple nutritional factors and the risk of Hashimoto’s thyroiditis. Thyroid 27(5):597–610. https://doi.org/10.1089/thy.2016.0635 CrossRefPubMed

Wang J, Lv S, Chen G, Gao C, He J, Zhong H, Xu Y (2015) Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients 7(4):2485–2498. https://doi.org/10.3390/nu7042485 CrossRefPubMedPubMedCentral

Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. https://doi.org/10.1186/1471-2288-14-135 CrossRefPubMedPubMedCentral

10.

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2018) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 22 Feb 2018

11.

Wacker M, Holick MF (2013) Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol 5(1):51–108. https://doi.org/10.4161/derm.24494 CrossRefPubMedPubMedCentral

12.

Grant WB, Bhattoa HP, Pludowski P (2017) Determinants of vitamin D deficiency from sun exposure: a global perspective. In: Feldman D, Pike JW, Bouillon R, Giovannucci E, Goltzman D, Hewison M (eds) Vitamin D: Volume 2: health, disease and therapeutics, 4th edn. Academic Press, London, pp 79–86

13.

Akaike H (1981) Likelihood of a model and information criteria. J Econom 16:3–14CrossRef

14.

Tamer G, Arik S, Tamer I, Coksert D (2011) Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid 21(8):891–896. https://doi.org/10.1089/thy.2009.0200 CrossRefPubMed

15.

Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Dankó K, Szekanecz Z, Langevitz P, Shoenfeld Y (2011) Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 8(3):243–247. https://doi.org/10.1038/cmi.2010.73 CrossRefPubMedPubMedCentral

16.

Camurdan OM, Döğer E, Bideci A, Celik N, Cinaz P (2012) Vitamin D status in children with Hashimoto thyroiditis. J Pediatr Endocrinol Metab 25(5–6):467–470PubMed

17.

Dellal F, Niyazoglu M, Ademoglu E, Gorar S, Candan Z, Bekdemir H, Uc ZA, Senes M, Ozderya A, Aral Y (2013) Evaluation of Serum trace elements and vitamin levels in Hashimoto’s thyroiditis: single centre experience from Turkey. Open J Endocr Metab Dis 3(4):236–240. https://doi.org/10.4236/ojemd.2013.34031 CrossRef

18.

Bozkurt NC, Karbek B, Ucan B, Sahin M, Cakal E, Ozbek M, Delibasi T (2013) The association between severity of vitamin D deficiency and Hashimoto’s thyroiditis. Endocr Pract 19(3):479–484. https://doi.org/10.4158/EP12376.OR CrossRefPubMed

19.

Mansournia N, Mansournia MA, Saeedi S, Dehghan J (2014) The association between serum 25OHD levels and hypothyroid Hashimoto’s thyroiditis. J Endocrinol Invest 37(5):473–476. https://doi.org/10.1007/s40618-014-0064-y CrossRefPubMed

20.

Botelho I (2014) Prevalence of Vitamin D insufficiency in patients with Hashimoto’s thyroiditis and its relationship with thyroid autoimmunity. Master’s thesis, Faculdade de Ciências Médicas, Universidade Estadual de Campinas Campinas, SP (Brasil). http://repositorio.unicamp.br/handle/REPOSIP/308788. Accessed 23 Sept 2018

21.

Unal AD, Tarcin O, Parildar H, Cigerli O, Eroglu H, Demirag NG (2014) Vitamin D deficiency is related to thyroid antibodies in autoimmune thyroiditis. Cent Eur J Immunol 39(4):493–497. https://doi.org/10.5114/ceji.2014.47735 CrossRefPubMedPubMedCentral

22.

Ma J, Wu D, Li C, Fan C, Chao N, Liu J, Li Y, Wang R, Miao W, Guan H, Shan Z, Teng W (2015) Lower serum 25-hydroxyvitamin D level is associated with 3 types of autoimmune thyroid diseases. Medicine (Baltimore) 94(39):e1639. https://doi.org/10.1097/MD.0000000000001639 CrossRef

23.

Lizis-Kolus K (2014) Ocena wpływu niedoboru witaminy D na przebieg choroby Hashimoto u chorych w województwie świętokrzyskim. Dissertation, Collegium Medicum, Wydział Lekarski, Uniwersytet Jagielloński, Kraków (Poland). http://dl.cm-uj.krakow.pl:8080/dlibra/docmetadata?id=4036. Accessed 23 Sept 2018

24.

Maciejewski A, Wójcicka M, Roszak M, Losy J, Łącka K (2015) Assessment of vitamin D level in autoimmune thyroiditis patients and a control group in the Polish population. Adv Clin Exp Med 24(5):801–806. https://doi.org/10.17219/acem/29183 CrossRefPubMed

25.

Evliyaoğlu O, Acar M, Özcabı B, Erginöz E, Bucak F, Ercan O, Kucur M (2015) Vitamin D deficiency and Hashimoto’s thyroiditis in children and adolescents: a critical vitamin D level for this Association? J Clin Res Pediatr Endocrinol 7(2):128–133. https://doi.org/10.4274/jcrpe.2011 CrossRefPubMedPubMedCentral

26.

Şıklar Z, Karataş D, Doğu F, Hacıhamdioğlu B, İkincioğulları A, Berberoğlu M (2016) Regulatory T cells and vitamin D status in children with chronic autoimmune thyroiditis. J Clin Res Pediatr Endocrinol 8(3):276–281. https://doi.org/10.4274/jcrpe.2766 CrossRefPubMedPubMedCentral

27.

Yasmeh J, Farpour F, Rizzo V, Kheradnam S, Sachmechi I (2016) Hashimoto thyroiditis not associated with vitamin D deficiency. Endocr Pract 22(7):809–813. https://doi.org/10.4158/EP15934.OR CrossRefPubMed

28.

Prasad I, Kumari R, Saran A (2016) Vitamin D evaluation in autoimmune thyroid diseases. Int J Contemp Med Res 3(12):3415–3418

29.

Guleryuz B, Akin F, Ata MT, Dalyanoglu MM, Turgut S (2016) Vitamin-D receptor (VDR) gene polymorphisms (TaqI, FokI) in Turkish patients with Hashimoto’s thyroiditis: relationship to the levels of Vit-D and cytokines. Endocr Metab Immune Disord Drug Targets 16(2):131–139. https://doi.org/10.2174/1871530316666160728092613 CrossRefPubMed

30.

Sönmezgöz E, Ozer S, Yilmaz R, Önder Y, Bütün I, Bilge S (2016) Hypovitaminosis D in children with Hashimoto’s thyroiditis. Rev Med Chil 144(5):611–616. https://doi.org/10.4067/S0034-98872016000500009 CrossRefPubMed

31.

Metwalley KA, Farghaly HS, Sherief T, Hussein A (2016) Vitamin D status in children and adolescents with autoimmune thyroiditis. J Endocrinol Invest 39(7):793–797. https://doi.org/10.1007/s40618-016-0432-x CrossRefPubMed

32.

Kim D (2016) Low vitamin D status is associated with hypothyroid Hashimoto’s thyroiditis. Hormones (Athens) 15(3):385–393. https://doi.org/10.14310/horm.2002.1681 CrossRef

33.

Priya R, Kalra P, Vashuda KC (2016) Autoimmune hypothyroidism and vitamin D levels. J Med Sci Clin Res 4(2):9453–9457. https://doi.org/10.18535/jmscr/v4i02.57 CrossRef

34.

Giovinazzo S, Vicchio TM, Certo R, Alibrandi A, Palmieri O, Campennì A, Cannavò S, Trimarchi F, Ruggeri RM (2017) Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D(3) levels in Hashimoto’s thyroiditis. Endocrine 55(2):599–606. https://doi.org/10.1007/s12020-016-0942-5 CrossRefPubMed

35.

Ke W, Sun T, Zhang Y, He L, Wu Q, Liu J, Zha B (2017) 25-hydroxyvitamin D serum level in Hashimoto’s thyroiditis, but not Graves’ disease is relatively deficient. Endocr J 64(6):581–587. https://doi.org/10.1507/endocrj.EJ16-0547 CrossRefPubMed

36.

Nalbant A, Gokosmanoglu F, Cinemre H, Varim C, Kaya T, Ergenc H (2017) The relation between serum vitamin D levels and Hashimoto thyroiditis in women. Kuwait Med J 49:223–226

37.

Yavuzer H, Işık S, Cengiz M, Bolayırlı IM, Döventaş A, Erdinçler DS (2017) The relationship between vitamin D levels and receptor activator of nuclear factor ligand in Hashimoto’s thyroiditis. Med Bull Haseki 55:261–268CrossRef

38.

Rezaee H, Najafipour F, Ranjdoust F, Sadra V, Hamishekar H, Najafipour M, Zareizadeh J, Janipour M (2017) Evaluation of serum vitamin D levels in patients with Hashimoto’s thyroiditis. Int J Adv Biotechnol Res 8:890–895

39.

Perga S, Martire S, Montarolo F, Giordani I, Spadaro M, Bono G, Corvisieri S, Messuti I, Panzica G, Orlandi F, Bertolotto A (2018) The footprints of poly-autoimmunity: evidence for common biological factors involved in multiple sclerosis and Hashimoto’s thyroiditis. Front Immunol 9:311. https://doi.org/10.3389/fimmu.2018.00311 CrossRefPubMedPubMedCentral

40.

Viechtbauer W, Cheung MW (2010) Outlier and influence diagnostics for meta-analysis. Res Synth Methods 1(2):112–125. https://doi.org/10.1002/jrsm.11 CrossRefPubMed

41.

Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF et al (2018) Rationale and plan for vitamin D food fortification: a review and guidance paper. Front Endocrinol (Lausanne) 9:373. https://doi.org/10.3389/fendo.2018.00373 CrossRef

42.

Jeffery LE, Raza K, Hewison M (2016) Vitamin D in rheumatoid arthritis-towards clinical application. Nat Rev Rheumatol 12(4):201–210. https://doi.org/10.1038/nrrheum.2015.140 CrossRefPubMed

43.

Edwards MH, Cole ZA, Harvey NC, Cooper C (2014) The global epidemiology of vitamin D status. J Aging Res Clin Pract 3(3):148–158

44.

Kimlin MG, Lucas RM, Harrison SL, van der Mei I, Armstrong BK, Whiteman DC, Kricker A, Nowak M, Brodie AM, Sun J (2014) The contributions of solar ultraviolet radiation exposure and other determinants to serum 25-hydroxyvitamin D concentrations in Australian adults: the AusD Study. Am J Epidemiol 179(7):864–874. https://doi.org/10.1093/aje/kwt446 CrossRefPubMed

45.

Nimitphong H, Holick MF (2013) Vitamin D status and sun exposure in southeast Asia. Dermatoendocrinol 5(1):34–37. https://doi.org/10.4161/derm.24054 CrossRefPubMedPubMedCentral

46.

Jungert A, Spinneker A, Nagel A, Neuhäuser-Berthold M (2014) Dietary intake and main food sources of vitamin D as a function of age, sex, vitamin D status, body composition, and income in an elderly German cohort. Food Nutr Res 58:23632. https://doi.org/10.3402/fnr.v58.23632 CrossRef

47.

Rabenberg M, Scheidt-Nave C, Busch MA, Rieckmann N, Hintzpeter B, Mensink GB (2015) Vitamin D status among adults in Germany–results from the German Health Interview and Examination Survey for Adults (DEGS1). BMC Public Health 15:641. https://doi.org/10.1186/s12889-015-2016-7 CrossRefPubMedPubMedCentral

48.

Moore CE, Radcliffe JD, Liu Y (2014) Vitamin D intakes of adults differ by income, gender and race/ethnicity in the U.S.A., 2007 to 2010. Public Health Nutr 17(4):756–763. https://doi.org/10.1017/S1368980013002929 CrossRefPubMed

49.

Arabi A, El Rassi R, El-Hajj Fuleihan G (2010) Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 6(10):550–561. https://doi.org/10.1038/nrendo.2010.146 CrossRefPubMed

50.

Novaković R, Cavelaars A, Geelen A, Nikolić M, Altaba II, Viñas BR, Ngo J, Golsorkhi M, Medina MW, Brzozowska A, Szczecinska A, de Cock D, Vansant G, Renkema M, Majem LS, Moreno LA, Glibetić M, Gurinović M, van’t Veer P, de Groot LC (2014) Socio-economic determinants of micronutrient intake and status in Europe: a systematic review. Public Health Nutr 17(5):1031–1045. https://doi.org/10.1017/S1368980013001341 CrossRefPubMed

51.

Moore CE, Radcliffe JD, Liu Y (2014) Vitamin D intakes of children differ by race/ethnicity, sex, age, and income in the United States, 2007 to 2010. Nutr Res 34(6):499–506. https://doi.org/10.1016/j.nutres.2014.06.002 CrossRefPubMed

52.

Voortman T, van den Hooven EH, Heijboer AC, Hofman A, Jaddoe VW, Franco OH (2015) Vitamin D deficiency in school-age children is associated with sociodemographic and lifestyle factors. J Nutr 145(4):791–798. https://doi.org/10.3945/jn.114.208280 CrossRefPubMed

53.

Darmon N, Drewnowski A (2008) Does social class predict diet quality? Am J Clin Nutr 87(5):1107–1117CrossRef

54.

Chaudhary A, Gustafson D, Mathys A (2018) Multi-indicator sustainability assessment of global food systems. Nat Commun 9(1):848. https://doi.org/10.1038/s41467-018-03308-7 CrossRefPubMedPubMedCentral

55.

Cashman KD, Sheehy T, O’Neill CM (2018) Is vitamin D deficiency a public health concern for low middle income countries? A systematic literature review. Eur J Nutr 58(1):433–453. https://doi.org/10.1007/s00394-018-1607-3 CrossRefPubMed

56.

Sørensen TH, Olsen KR, Vedsted P (2009) Association between general practice referral rates and patients’ socioeconomic status and access to specialized health care a population-based nationwide study. Health Policy 92(2–3):180–186. https://doi.org/10.1016/j.healthpol.2009.03.011 CrossRefPubMed

57.

Hansen RP, Olesen F, Sørensen HT, Sokolowski I, Søndergaard J (2008) Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res 8:49. https://doi.org/10.1186/1472-6963-8-49 CrossRefPubMedPubMedCentral

58.

Beedasy J (2010) Rural designations and geographic access to tertiary healthcare in Idaho. Online J Rural Res Policy 5(2):1–21. https://doi.org/10.4148/ojrrp.v5i2.191 CrossRef

59.

Hauch A, Al-Qurayshi Z, Friedlander P, Kandil E (2014) Association of socioeconomic status, race, and ethnicity with outcomes of patients undergoing thyroid surgery. JAMA Otolaryngol Head Neck Surg 140(12):1173–1183. https://doi.org/10.1001/jamaoto.2014.1745 CrossRefPubMed

60.

Taylor PN, Iqbal A, Minassian C, Sayers A, Draman MS, Greenwood R, Hamilton W, Okosieme O, Panicker V, Thomas SL, Dayan C (2014) Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med 174(1):32–39. https://doi.org/10.1001/jamainternmed.2013.11312 CrossRefPubMed

61.

Mammen JS, McGready J, Oxman R, Chia CW, Ladenson PW, Simonsick EM (2015) Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the Baltimore longitudinal study of aging. Thyroid 25(9):979–986. https://doi.org/10.1089/thy.2015.0180 CrossRefPubMedPubMedCentral

62.

Somwaru LL, Arnold AM, Cappola AR (2011) Predictors of thyroid hormone initiation in older adults: results from the cardiovascular health study. J Gerontol A Biol Sci Med Sci 66(7):809–814. https://doi.org/10.1093/gerona/glr063 CrossRefPubMed

63.

Olmos RD, Figueiredo RC, Aquino EM, Lotufo PA, Bensenor IM (2015) Gender, race and socioeconomic influence on diagnosis and treatment of thyroid disorders in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Braz J Med Biol Res 48(8):751–758. https://doi.org/10.1590/1414-431X20154445 CrossRefPubMedPubMedCentral

64.

Thvilum M, Brandt F, Brix TH, Hegedüs L (2014) Hypothyroidism is a predictor of disability pension and loss of labor market income: a Danish register-based study. J Clin Endocrinol Metab 99(9):3129–3135. https://doi.org/10.1210/jc.2014-1407 CrossRefPubMed

65.

Ott J, Promberger R, Kober F, Neuhold N, Tea M, Huber JC, Hermann M (2011) Hashimoto’s thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 21(2):161–167. https://doi.org/10.1089/thy.2010.0191 CrossRefPubMed

66.

Rhee CM, Chen Y, You AS, Brunelli SM, Kovesdy CP, Budoff MJ, Brent GA, Kalantar-Zadeh K, Nguyen DV (2017) Thyroid status, quality of life, and mental health in patients on hemodialysis. Clin J Am Soc Nephrol 12(8):1274–1283. https://doi.org/10.2215/CJN.13211216 CrossRefPubMedPubMedCentral

67.

Samuels MH (2014) Psychiatric and cognitive manifestations of hypothyroidism. Curr Opin Endocrinol Diabetes Obes 21(5):377–383. https://doi.org/10.1097/MED.0000000000000089 CrossRefPubMedPubMedCentral

68.

Vigário Pdos S, Vaisman F, Coeli CM, Ward L, Graf H, Carvalho G, Júnior RM, Vaisman M (2013) Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life-a Brazilian multicentre study. Endocrine 44(2):434–440. https://doi.org/10.1007/s12020-013-9886-1 CrossRefPubMed

69.

Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L (2018) Over- and under-treatment of hypothyroidism is associated with excess mortality: a register-based cohort study. Thyroid 28(5):566–574. https://doi.org/10.1089/thy.2017.0517 CrossRefPubMed

70.

Thvilum M, Brandt F, Almind D, Christensen K, Brix TH, Hegedüs L (2013) Type and extent of somatic morbidity before and after the diagnosis of hypothyroidism. A nationwide register study. PLoS ONE 8(9):e75789. https://doi.org/10.1371/journal.pone.0075789 CrossRefPubMedPubMedCentral

71.

Feller M, Snel M, Moutzouri E, Bauer DC, de Montmollin M, Aujesky D, Ford I, Gussekloo J, Kearney PM, Mooijaart S, Quinn T, Stott D, Westendorp R, Rodondi N, Dekkers OM (2018) Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA 320(13):1349–1359. https://doi.org/10.1001/jama.2018.13770 CrossRefPubMedPubMedCentral

72.

Klaver EI, van Loon HC, Stienstra R, Links TP, Keers JC, Kema IP, Kobold AC, van der Klauw MM, Wolffenbuttel BH (2013) Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study. Thyroid 23(9):1066–1073. https://doi.org/10.1089/thy.2013.0017 CrossRefPubMedPubMedCentral

73.

Ovesen L, Andersen R, Jakobsen J (2003) Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 62(4):813–821CrossRef

74.

Johnson LK, Hofsø D, Aasheim ET, Tanbo T, Holven KB, Andersen LF, Røislien J, Hjelmesæth J (2012) Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional study. Eur J Clin Nutr 66(1):83–90. https://doi.org/10.1038/ejcn.2011.140 CrossRefPubMed

75.

Poomthavorn P, Saowan S, Mahachoklertwattana P, Chailurkit L, Khlairit P (2012) Vitamin D status and glucose homeostasis in obese children and adolescents living in the tropics. Int J Obes (Lond) 36(4):491–495. https://doi.org/10.1038/ijo.2011.260 CrossRef

76.

Saneei P, Salehi-Abargouei A, Esmaillzadeh A (2013) Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 14(5):393–404. https://doi.org/10.1111/obr.12016 CrossRefPubMed

77.

Ahern T, Khattak A, O’Malley E, Dunlevy C, Kilbane M, Woods C, McKenna MJ, O’Shea D (2014) Association between vitamin D status and physical function in the severely obese. J Clin Endocrinol Metab 99(7):E1327–E1331. https://doi.org/10.1210/jc.2014-1704 CrossRefPubMed

78.

Pourshahidi LK (2015) Vitamin D and obesity: current perspectives and future directions. Proc Nutr Soc 74(2):115–124. https://doi.org/10.1017/S0029665114001578 CrossRefPubMed

79.

Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L, Jørgensen T (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90(7):4019–4024CrossRef

80.

Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L (2018) Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol 6(12):944–953. https://doi.org/10.1016/S2213-8587(18)30288-2 CrossRefPubMedPubMedCentral

81.

Wang S, Wu Y, Zuo Z, Zhao Y, Wang K (2018) The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis. Endocrine 59(3):499–505. https://doi.org/10.1007/s12020-018-1532-5 CrossRefPubMed

82.

Major JM, Graubard BI, Dodd KW, Iwan A, Alexander BH, Linet MS, Freedman DM (2013) Variability and reproducibility of circulating vitamin D in a nationwide U.S. population. J Clin Endocrinol Metab 98(1):97–104. https://doi.org/10.1210/jc.2012-2643 CrossRefPubMed

83.

Gail MH, Wu J, Wang M, Yaun SS, Cook NR, Eliassen AH, McCullough ML, Yu K, Zeleniuch-Jacquotte A, Smith-Warner SA, Ziegler RG, Carroll RJ (2016) Calibration and seasonal adjustment for matched case-control studies of vitamin D and cancer. Stat Med 35(13):2133–2148. https://doi.org/10.1002/sim.6856 CrossRefPubMedPubMedCentral

84.

Jiang X, O’Reilly PF, Aschard H, Hsu YH, Richards JB, Dupuis J et al (2018) Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun 9(1):260. https://doi.org/10.1038/s41467-017-02662-2 CrossRefPubMedPubMedCentral

85.

Black LJ, Seamans KM, Cashman KD, Kiely M (2012) An updated systematic review and meta-analysis of the efficacy of vitamin D food fortification. J Nutr 142(6):1102–1108. https://doi.org/10.3945/jn.112.158014 CrossRefPubMed

86.

Enko D, Fridrich L, Rezanka E, Stolba R, Ernst J, Wendler I, Fabian D, Hauptlorenz S, Halwachs-Baumann G (2014) 25-hydroxy-vitamin D status: limitations in comparison and clinical interpretation of serum-levels across different assay methods. Clin Lab 60(9):1541–1550PubMed

87.

Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick MF (1999) An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9(5):394–397CrossRef

88.

Jones G (2015) Interpreting vitamin D assay results: proceed with caution. Clin J Am Soc Nephrol 10(2):331–334. https://doi.org/10.2215/CJN.05490614 CrossRefPubMed

89.

Black LJ, Anderson D, Clarke MW, Ponsonby AL, Lucas RM, Autoimmune Investigator Group (2015) Analytical bias in the measurement of serum 25-hydroxyvitamin D concentrations impairs assessment of vitamin D status in clinical and research settings. PLoS ONE 10(8):e0135478. https://doi.org/10.1371/journal.pone.0135478 CrossRefPubMedPubMedCentral

Title: Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto’s thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies
Authors: Mario Štefanić
Stana Tokić
Publication date: 01-04-2020
Publisher: Springer Berlin Heidelberg
Keyword: Hashimoto Thyroiditis
Published in: European Journal of Nutrition / Issue 3/2020
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-019-01991-w

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2020

Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study

Consumption of modern and traditional Moroccan dairy products and colorectal cancer risk: a large case control study

Fatty acid intake and breast cancer in the Spanish multicase–control study on cancer (MCC-Spain)

Post-cancer diagnosis dietary inflammatory potential is associated with survival among women diagnosed with colorectal cancer in the Women’s Health Initiative

Adherence to a priori dietary indexes and baseline prevalence of cardiovascular risk factors in the PREDIMED-Plus randomised trial

Effects of dietary glutamine supplementation on immune cell polarization and muscle regeneration in diabetic mice with limb ischemia

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage